Applicants will normally be required to hold at least upper second-class Honours degree (2.1) or higher in Medicine, Veterinary Science, Molecular Biology, Genetics, Immunology, Biochemistry or a related subject.
All applicants to Trinity are required to provide official evidence of proficiency in the English language. Applicants to this course are required to meet
Band B (Standard Entry)
English language requirements. For more details of qualifications that meet Band B, see the English Language Requirements page
This one-year Masters course in Immunotherapeutics is an innovative and multidisciplinary postgraduate degree taught by leading academics in the field of Immunology with guest speakers from the biopharma industry. Students will learn about the immune system in cancer, autoimmunity, infection and neurodegeneration, and how cutting-edge immunotherapies are revolutionising the treatment of life-threatening and debilitating diseases. This course also includes the study of the exciting technologies of DNA / RNA vaccines, antibody, stem cell and CAR T-cell therapies, as well as immune-checkpoint blockade. Additionally, skills in business development, innovation, entrepreneurship and communication will be taught and bioprocessing in the National Institute for Bioprocessing, Research and Training (NIBRT) at their state-of- the-art facility. A key component of the course is the six-month industry placement to be completed by each student in collaboration with an academic staff member. Is This Course For Me? The M.Sc. in Immunotherapeutics is open to scientific, medical, dentistry, veterinary, and engineering graduates who wish to obtain in-depth knowledge of Immunotherapeutics, fundamental immunology and the technologies that underpin immunotherapeutic development. This programme is particularly suitable for graduates who wish to work in high-level jobs in the Biopharma industry or continue further academic research.